TNF and melanoma: miR-134 acts as an immune escape facilitator in melanoma cells, not only directly targeting B7-2 to reduce its expression, but also mediating the reduction of interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α) levels produced by lymphocytes (62).